Hexapeptides of Neisseria gonorrhoeae
AssigneeBehringwerke Aktiengesellschaft
InventorsCharles Garrett Miyada, Teresa L. Born
Life of this patent
Estimating the term…
Loading patent…
AssigneeBehringwerke Aktiengesellschaft
InventorsCharles Garrett Miyada, Teresa L. Born
Estimating the term…
A nucleotide sequence characteristic of Neisseria gonorrhoeae is disclosed. The sequence can be the basis for hybridization type, nucleic acid-based, rapid, in vitro diagnostic assays. The unique nature of the sequence makes it possible to clearly discriminate N. gonorrhoeae from other Neisseria species thus eliminating or substantially reducing the number of false positive readings. A 350 base pair N. gonorrhoeae DNA restriction fragment was cloned after subtractive hybridization to Neisseria meningitidis DNA. In further cloning experiments the sequences adjacent to the original 350 base pair fragment were determined. A portion of this sequence was shown to detect 105 of 106 N. gonorrhoeae strains and no other Neisseria species. In addition to use as detection probes, all or portions of the nucleotide sequence can be used as a ligand for the sandwich capture of N. gonorrhoeae sequences and as primers for in vitro amplification of N. gonorrhoeae sequences. The polypeptides encoded by the presently disclosed sequence, including antibodies thereto, are also disclosed as are their uses.
A hexapeptide fragment of the amino acid sequence of SEQ ID NO:
The hexapeptide AlaArgLeuValMetLeu (amino acids 247-252 of SEQ ID NO:
Dependencies are inferred from the claim text.